N-乙酰基-酪氨酰-缬氨酰-丙氨酰-天冬氨酸-7-氨基-4-甲基香豆素结构式
|
常用名 | N-乙酰基-酪氨酰-缬氨酰-丙氨酰-天冬氨酸-7-氨基-4-甲基香豆素 | 英文名 | Ac-Tyr-Val-Ala-Asp-AMC |
|---|---|---|---|---|
| CAS号 | 149231-65-2 | 分子量 | 665.690 | |
| 密度 | 1.3±0.1 g/cm3 | 沸点 | 1127.3±65.0 °C at 760 mmHg | |
| 分子式 | C33H39N5O10 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 635.6±34.3 °C |
| 中文名 | N-乙酰基-酪氨酰-缬氨酰-丙氨酰-天冬氨酸-7-氨基-4-甲基香豆素 |
|---|---|
| 英文名 | 3-[2-[[2-[[2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]propanoylamino]-4-[(4-methyl-2-oxochromen-7-yl)amino]-4-oxobutanoic acid |
| 中文别名 | 蛋白酶1底物2m.荧光 | N-乙酰基-L-酪氨酰-L-缬氨酰-L-丙氨酰-N-(4-甲基-2-氧代-2H-1-苯并吡喃-7-基)-L-alpha-天冬氨酰胺 |
| 英文别名 | 更多 |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 沸点 | 1127.3±65.0 °C at 760 mmHg |
| 分子式 | C33H39N5O10 |
| 分子量 | 665.690 |
| 闪点 | 635.6±34.3 °C |
| 精确质量 | 665.269714 |
| PSA | 233.24000 |
| LogP | 2.58 |
| InChIKey | YGLOALWHJIANIH-PQTMRPCPSA-N |
| SMILES | CC(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)Nc1ccc2c(C)cc(=O)oc2c1)C(C)C |
| 外观性状 | 白色粉末 |
| 蒸汽压 | 0.0±0.3 mmHg at 25°C |
| 折射率 | 1.605 |
| 储存条件 | 保存方法: -20 °C |
| 水溶解性 | DMSO: 10 mM The solution is stable in the dark at −20 °C for more than 1 month if no water is present. |
| 分子结构 | 1、摩尔折射率:170.46 2、摩尔体积(cm3/mol):495.1 3、等张比容(90.2K):1389.6 4、表面张力(dyne/cm):62 5、介电常数:无可用的 6、极化率(10-24cm3):67.57 7、单一同位素质量:665.269692 Da 8、标称质量:665 Da 9、平均质量:665.6903 Da |
| 计算化学 | 1.疏水参数计算参考值(XlogP):1.3 2.氢键供体数量:7 3.氢键受体数量:10 4.可旋转化学键数量:14 5.互变异构体数量:640 6.拓扑分子极性表面积229 7.重原子数量:48 8.表面电荷:0 9.复杂度:1260 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:4 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
| 更多 | 1. 性状:白色粉末 2. 密度(g/mL, 20 ℃ ):未确定 3. 相对蒸汽密度(g/mL,空气=1):未确定 4. 熔点(ºC):未确定 5. 沸点(ºC,常压):未确定 6. 沸点(ºC 10mmHg):未确定 7. 折射率:未确定 8. 闪点(ºF):未确定 9. 比旋光度(º):未确定 10. 自燃点或引燃温度(ºC):不适用的 11. 蒸气压(kPa,25ºC):未确定 12. 饱和蒸气压(kPa,60ºC):未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(ºC):未确定 15. 临界压力(KPa):未确定 16. 油水(辛醇/水)分配系数的对数值:未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性:溶于DMSO |
| 危险品运输编码 | NONH for all modes of transport |
|---|---|
| WGK德国 | 3 |
|
A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.
Nature 356 , 768, (1992) Interleukin-1 beta (IL-1 beta)-converting enzyme cleaves the IL-1 beta precursor to mature IL-1 beta, an important mediator of inflammation. The identification of the enzyme as a unique cysteine prote... |
|
|
Processing/activation of CPP32-like proteases is involved in transforming growth factor beta1-induced apoptosis in rat hepatocytes.
Hepatology 25 , 1516, (1997) Apoptosis induced in rat hepatocytes by transforming growth factor beta1 (TGF-beta1) was accompanied by the activation of interleukin-1beta converting enzyme (ICE)-like proteases. Cell lysates were is... |
|
|
Partial purification and characterization of two distinct types of caspases from human epidermis.
J. Invest. Dermatol. 111 , 367-372, (1998) Recent observations demonstrated that interleukin-1beta converting enzyme family proteases, now referred to as caspase family, play central roles in apoptosis, or programmed cell death. In this study,... |
| acetyl-YVAD-aminomethyl coumarine |
| Ac-Tyr-Val-Ala-Asp-7-Amino-4-Methylcoumarin |
| N-Acetyl-L-tyrosyl-L-valyl-L-alanyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)-L-α-asparagine |
| Acetyl-YVAD-AMC |
| N-Acetyl-Tyr-Val-Ala-Asp-7-amido-4-methylcoumarin |
| MFCD00171369 |
| Ac-Tyr-Val-Ala-Asp-MCA |
| Ac-YVAD-AMC |
| Ac-Tyr-Val-Ala-Asp-AMC |
| AMC120 |
| AC-YVAD-AMC |
| AC-TYR-VAL-ALA-ASP-AMC |